| Katherine Mae Poquiz Jose, DO, MBA | |
|
5220 W University Dr, Suite 100, Mckinney, TX 75071-7064 | |
| (469) 800-5100 | |
| (469) 800-5110 |
| Full Name | Katherine Mae Poquiz Jose |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 5220 W University Dr, Mckinney, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972948883 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | Q4997 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Home Health Group Of Mckinney, Llc | Mckinney, TX | Home health agency |
| Baylor Scott And White Medical Center Mckinney | Mc kinney, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
News Archive
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for another crucial patent covering its leading tumor-targeted gene delivery platform. The issuance of this high-value patent protection for targeting metastatic disease follows on the heels of two major patent issuances covering tumor-targeted gene delivery and precision-targeted cancer immunotherapy, respectively.
TWi Pharmaceuticals, Inc. today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc. (individually and collectively, "Takeda") to settle and dismiss all outstanding patent litigation related to TWi's generic dexlansoprazole delayed release capsules for oral administration in 30 mg and 60 mg dosage strengths.
Most parents who yell at their adolescent children wouldn't dream of physically punishing their teens. Yet their use of harsh verbal discipline-defined as shouting, cursing, or using insults-may be just as detrimental to the long-term well-being of adolescents.
Writing in the Center for Global Development's "Views From The Center" blog about the creation of a hedging tool by the World Bank and J.P. Morgan to help protect farmers from volatile food prices in developing countries, CGD Vice President for Corporate Affairs Todd Moss says that having safeguards in place to "prevent speculation or abuse" and "credible private sector partners will be essential" to the program's success.
For the first time, scientists have linked a brain compound called kynurenic acid to cognition, possibly opening doors for new ways to enhance memory function and treat catastrophic brain diseases, according to a new study from the University of Maryland School of Medicine. When researchers decreased the levels of kynurenic acid in the brains of mice, their cognition was shown to improve markedly, according to the study, which was published in the July issue of the journal Neuropsychopharmacology.
› Verified 2 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for another crucial patent covering its leading tumor-targeted gene delivery platform. The issuance of this high-value patent protection for targeting metastatic disease follows on the heels of two major patent issuances covering tumor-targeted gene delivery and precision-targeted cancer immunotherapy, respectively.
TWi Pharmaceuticals, Inc. today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc. (individually and collectively, "Takeda") to settle and dismiss all outstanding patent litigation related to TWi's generic dexlansoprazole delayed release capsules for oral administration in 30 mg and 60 mg dosage strengths.
Most parents who yell at their adolescent children wouldn't dream of physically punishing their teens. Yet their use of harsh verbal discipline-defined as shouting, cursing, or using insults-may be just as detrimental to the long-term well-being of adolescents.
Writing in the Center for Global Development's "Views From The Center" blog about the creation of a hedging tool by the World Bank and J.P. Morgan to help protect farmers from volatile food prices in developing countries, CGD Vice President for Corporate Affairs Todd Moss says that having safeguards in place to "prevent speculation or abuse" and "credible private sector partners will be essential" to the program's success.
For the first time, scientists have linked a brain compound called kynurenic acid to cognition, possibly opening doors for new ways to enhance memory function and treat catastrophic brain diseases, according to a new study from the University of Maryland School of Medicine. When researchers decreased the levels of kynurenic acid in the brains of mice, their cognition was shown to improve markedly, according to the study, which was published in the July issue of the journal Neuropsychopharmacology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Mae Poquiz Jose, DO, MBA 5220 W University Dr, Suite 100, Mckinney, TX 75071-7064 Ph: (469) 800-5100 | Katherine Mae Poquiz Jose, DO, MBA 5220 W University Dr, Suite 100, Mckinney, TX 75071-7064 Ph: (469) 800-5100 |
News Archive
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for another crucial patent covering its leading tumor-targeted gene delivery platform. The issuance of this high-value patent protection for targeting metastatic disease follows on the heels of two major patent issuances covering tumor-targeted gene delivery and precision-targeted cancer immunotherapy, respectively.
TWi Pharmaceuticals, Inc. today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc. (individually and collectively, "Takeda") to settle and dismiss all outstanding patent litigation related to TWi's generic dexlansoprazole delayed release capsules for oral administration in 30 mg and 60 mg dosage strengths.
Most parents who yell at their adolescent children wouldn't dream of physically punishing their teens. Yet their use of harsh verbal discipline-defined as shouting, cursing, or using insults-may be just as detrimental to the long-term well-being of adolescents.
Writing in the Center for Global Development's "Views From The Center" blog about the creation of a hedging tool by the World Bank and J.P. Morgan to help protect farmers from volatile food prices in developing countries, CGD Vice President for Corporate Affairs Todd Moss says that having safeguards in place to "prevent speculation or abuse" and "credible private sector partners will be essential" to the program's success.
For the first time, scientists have linked a brain compound called kynurenic acid to cognition, possibly opening doors for new ways to enhance memory function and treat catastrophic brain diseases, according to a new study from the University of Maryland School of Medicine. When researchers decreased the levels of kynurenic acid in the brains of mice, their cognition was shown to improve markedly, according to the study, which was published in the July issue of the journal Neuropsychopharmacology.
› Verified 2 days ago
George W Childress, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6171 Virginia Pkwy Ste 200, Mckinney, TX 75071 Phone: 972-548-5377 Fax: 972-548-5447 | |
Melony Ann Chilcoat, APRN, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2740 Virginia Pkwy Ste 100, Mckinney, TX 75071 Phone: 214-414-2880 Fax: 214-279-9639 | |
Dr. Kedrica Massa Taylor, DNP, APRN, FNP-BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1703 Rockhill Rd Apt 1131, Mckinney, TX 75069 Phone: 918-408-0560 | |
Dr. John L Washburn Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5220 W University Dr Ste 100, Mckinney, TX 75071 Phone: 469-800-5100 Fax: 469-800-5110 | |
Tina M Gingrich, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4510 Medical Center Dr, Mckinney, TX 75069 Phone: 214-295-8675 Fax: 866-207-2534 | |
Ambreen Ashfaque, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4201 Medical Center Dr, Suite 380, Mckinney, TX 75069 Phone: 972-529-6939 Fax: 972-529-6935 | |
Mr. Billy R Boring Jr., MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1441 Redbud Blvd, Ste 111, Mckinney, TX 75069 Phone: 972-542-2683 Fax: 972-548-7657 |